Apotex Health Corp. APTX.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · apotex.com
Apotex Health is the largest Canadian-based pharmaceutical company, developing, manufacturing, and distributing generic pharmaceuticals, oncology biosimilars, branded specialty pharmaceuticals, and consumer health and wellness products across Canada, the United States, Mexico, and India. Founded in 1974 and headquartered in Toronto, it began trading on the TSX in June 2026 in the largest life-sciences IPO in TSX history, raising about $1.5 billion.
Key ratios
CashFromOperationsYoYGrowth TTM 0.16
CashFromOperationsYoYGrowth 2026 0.16
CashFromOperationsYoYGrowth 2025 -0.03
DilutedEPSYoYGrowth TTM 1.39
DilutedEPSYoYGrowth 2026 1.39
FreeCashFlowOnSale TTM 0.15
FreeCashFlowOnSale 2026 0.15
FreeCashFlowOnSale 2025 0.14
FreeCashFlowOnSale 2024 0.17
NetIncomeMargin TTM 0.11
NetIncomeMargin 2026 0.11
NetIncomeMargin 2025 0.05
NetIncomeMargin 2024 -0.05
ReturnOnAssets 2026 0.14
ReturnOnAssets 2025 0.14
ReturnOnEquity TTM 0.3
ReturnOnEquity 2025 0.3
TotalRevenueYoYGrowth TTM 0.04
TotalRevenueYoYGrowth 2026 0.04
TotalRevenueYoYGrowth 2025 0.14
Recent news
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
2026-07-16 · CNW
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
2026-07-09 · CNW
Apotex Expands U.S. Hospital Portfolio with Launch of Generic Infuvite Adult and Pediatric Injection
2026-07-08 · Newswire (CNW)
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
2026-07-01 · Newswire (CNW)